Benjamin Krohn-Hansen

Benjamin Krohn-Hansen

Auto-generated profile, based on publicly available information

Benjamin Krohn-Hansen

Department of Chemistry and Biochemistry, University of California, Santa Barbara, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2023 in Nature Catalysis
Verified
Journal Article
Closed access
PDF file
WFWenzhen Fu
Wenzhen Fu
NNNatalia M. Neris
Natalia M. Neris
YFYue Fu
Yue Fu
YZYunlong Zhao
Yunlong Zhao
BKBenjamin Krohn-Hansen
Benjamin Krohn-Hansen
YYYang Yang
Yang Yang

14 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SJShuyun Ju
Shuyun Ju
KKKaylee P. Kuzelka
Kaylee P. Kuzelka
RGRui Guo
Rui Guo
BKBenjamin Krohn-Hansen
Benjamin Krohn-Hansen
JWJianping Wu
Jianping Wu
YYYang Yang
Yang Yang
Catalytic asymmetric α-alkylation of carbonyl compounds represents a long-standing challenge in synthetic organic chemistry. Herein, we advance a dual biocatalytic platform for the efficient asymmetric alkylation of α-keto acids. First, guided by our recently obtained crystal structures, we develop SgvMVAV as a general biocatalyst for the enantioselective methylation, ethylation, allylation and propargylation of a range of α-keto acids with total turnover numbers (TTNs) up to 4,600. Second, we mine a family of bacterial HMTs from Pseudomonas species sharing less than 50% sequence identities with known HMTs and evaluated their activities in SAM regeneration. Our best performing HMT from P. aeruginosa, PaHMT, displays the highest SAM regeneration efficiencies (TTN up to 7,700) among HMTs characterized to date. Together, the synergistic use of SgvMVAV and PaHMT affords a fully biocatalytic protocol for asymmetric methylation featuring a record turnover efficiency, providing a solution to the notorious problem of asymmetric alkylation.